Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update
- Monday, August 14, 2023, 7:02
- Finance
- Add a comment
─On Track to Achieve CM-101 PSC Phase 2 Readout Expected in 2H2024— ─Extended Estimated Cash Runway Through PSC Readout and 2024 Year-End─ ─Reported Positive Secondary Analysis of Data from CM-101 Phase 2 Liver Fibrosis Trial─ ─Successfully Implemented Senior Management Changes and Cost…
About the Author
adminasapcorp has written 38957 stories on this site.